Establishing Management Framework for Biosafety Risk Assessments of Synthetic Biology

Synthetic biology, an evolving interdisciplinary field encompassing revolutionary technologies, requires a comprehensive consideration of bioethics, and biosafety risks to drive scientific and technological advancements. To address these concerns, it is crucial to pay attention to synthetic biology governance, ethics principles, and legal regulations, and develop appropriate biosafety risk assessment frameworks. This study endeavors to delve into the strategies of biosafety as well as the governance of risk assessment to foster innovation in the field of synthetic biology. It provides proposals to facilitate the healthy progression of synthetic biology and enhance biosafety management infrastructure. Emphasizing the critical facets of bio-risk assessment in synthetic biology, this work particularly underscores the biosafety risks associated with various factors and methods of the biosafety risk assessment. Within this context, the assessment of biosafety risk in the implementation of synthetic biology technology requires a comprehensive evaluation. Professional technical capabilities, the accessibility of the required resources and organizational scope should be considered when it comes to the actors of synthetic biology.

Authors

Institutions

Publication Details

Journal
Laboratories
Published
2026-09-22
DOI
https://doi.org/10.3390/laboratories3040024
Primary Topic
Genetically Modified Organisms Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Establishing Management Framework for Biosafety Risk Assessments of Synthetic Biology

李纪元, Kunlan Zuo, Lu Zhang, Huan Liu et al.
Laboratories
Genetically Modified Organisms Research
article

Establishing Management Framework for Biosafety Risk Assessments of Synthetic Biology

李纪元, Kunlan Zuo, Lu Zhang, Huan Liu, Qiangyu Xiang, Qianneng Lu, Shenshen Yan, Ruipeng Lei
article en

Abstract

Synthetic biology, an evolving interdisciplinary field encompassing revolutionary technologies, requires a comprehensive consideration of bioethics, and biosafety risks to drive scientific and technological advancements. To address these concerns, it is crucial to pay attention to synthetic biology governance, ethics principles, and legal regulations, and develop appropriate biosafety risk assessment frameworks. This study endeavors to delve into the strategies of biosafety as well as the governance of risk assessment to foster innovation in the field of synthetic biology. It provides proposals to facilitate the healthy progression of synthetic biology and enhance biosafety management infrastructure. Emphasizing the critical facets of bio-risk assessment in synthetic biology, this work particularly underscores the biosafety risks associated with various factors and methods of the biosafety risk assessment. Within this context, the assessment of biosafety risk in the implementation of synthetic biology technology requires a comprehensive evaluation. Professional technical capabilities, the accessibility of the required resources and organizational scope should be considered when it comes to the actors of synthetic biology.

LaboratoriesVol. 3(4)
University of Science and Technology of China (CN), University of Electronic Science and Technology of China (CN), Harbin Institute of Technology (CN), Wuhan Institute of Virology (CN), State Key Laboratory of Virology
Industry, innovation and infrastructure
Openalex Percentile: Top 13%
Genetically Modified Organisms Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Establishing Management Framework for Biosafety Risk Assessments of Synthetic Biology — 李纪元, Kunlan Zuo, et al. · Laboratories (2026) | TGRS Research Map | TGRS